Taiwan has recently been hit by rabies, but due to a lack of funding, the government has not been able to purchase an adequate amount of vaccine. Cuts to HIV/AIDS medication funding have been suggested as one solution to the lack of money available for rabies vaccines because the proportion of funds for national disease prevention that go toward HIV/AIDS medication is so high.
Published: September 1, 2013
With an increase in the number of people with HIV and yearly increases in HIV/AIDS-related expenses, the government’s funding strategy has been to continue negotiations to lower the costs of drugs and limit the number of drug combinations available for people with the disease.
For drug companies, lowering costs means a drop in profits which could have repercussions on investment in development and quality control. This could slow down the development of new drugs, while also lowering the chances of those drugs coming into Taiwan.
For people with HIV, restricting drug alternatives means that their options are limited if the initial drug combination is not effective, which is wasteful. Bad experiences with certain drug combinations for patients could make them afraid to receive additional medical treatment.
And reducing HIV/AIDS treatment costs by negotiating prices downward is obviously not an effective means to lower the number of new infections.
Due to the design of Taiwan’s medical system and because HIV is a communicable disease, the Centers for Disease Control (CDC) has been responsible for management of the disease for a long time. However, given that the vast majority of people with the disease now survive for a long time and because the number of newly infected people continues to rise, the government should rethink which of its departments are responsible for HIV/AIDS-related costs.
Full text of article available at link below –